Literature DB >> 9663593

Oral snuff, smoking habits and alcohol consumption in relation to oral cancer in a Swedish case-control study.

E B Schildt1, M Eriksson, L Hardell, A Magnuson.   

Abstract

The use of oral snuff is a widespread habit in Sweden. We investigated whether the use of Swedish moist snuff leads to an increasing risk of oral cancer. Other risk factors such as smoking tobacco and alcoholic beverages were also investigated. Our study comprised 410 patients with oral cancer, from the period 1980-1989, and 410 matched controls. All subjects received a mailed questionnaire. The response rates were 96% and 91% for cases and controls, respectively. In the study, a total of 20% of all subjects, cases and controls, were active or ex-snuff users. The univariate analysis did not show any increased risk [odds ratio (OR) 0.7, 95% confidence interval (CI) 0.4-1.1] for active snuff users. We found an increased risk (OR 1.8, CI 1.1-2.7) for oral cancer among active smokers. Alcohol consumption showed the strongest risk for oral cancer. Among consumers of beer, an increased risk of 1.9 (CI 0.9-3.9) was found. Corresponding ORs for wine and liquor were 1.3 (CI 0.9-1.8) and 1.6 (CI 1.1-2.3), respectively. A dose-response effect was observed. Although not statistically significant, a multivariate analysis similarly suggested that the most important risk factors were beer and liquor consumption, followed by smoking.

Entities:  

Mesh:

Year:  1998        PMID: 9663593     DOI: 10.1002/(sici)1097-0215(19980729)77:3<341::aid-ijc6>3.0.co;2-o

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  38 in total

1.  Swedish Match Company, Swedish snus and public health: a harm reduction experiment in progress?

Authors:  J E Henningfield; K O Fagerstrom
Journal:  Tob Control       Date:  2001-09       Impact factor: 7.552

2.  Analysis of P53 mutation and invasion front grading in oral squamous cell carcinomas.

Authors:  Sanbao Tang; Dongxuan Xu; Bin Zhou
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-08-17

3.  Public health implications of smokeless tobacco use as a harm reduction strategy.

Authors:  David A Savitz; Roger E Meyer; Jason M Tanzer; Sidney S Mirvish; Freddi Lewin
Journal:  Am J Public Health       Date:  2006-10-03       Impact factor: 9.308

4.  Smokeless tobacco brand switching: a means to reduce toxicant exposure?

Authors:  D K Hatsukami; J O Ebbert; A Anderson; H Lin; C Le; S S Hecht
Journal:  Drug Alcohol Depend       Date:  2006-09-20       Impact factor: 4.492

Review 5.  Systematic review of the relation between smokeless tobacco and cancer in Europe and North America.

Authors:  Peter N Lee; Jan Hamling
Journal:  BMC Med       Date:  2009-07-29       Impact factor: 8.775

6.  The burden of mortality from smoking: comparing Sweden with other countries in the European Union.

Authors:  Brad Rodu; Philip Cole
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

7.  Analysis of cadmium, nickel, and lead in commercial moist and dry snuff used in Pakistan.

Authors:  Tasneem Gul Kazi; Sadaf Sadia Arain; Hassan Imran Afridi; Kapil Dev Brahman; Nida Fatima Kolachi; Moina Akhtar Mughal
Journal:  Environ Monit Assess       Date:  2012-10-14       Impact factor: 2.513

8.  The STAGE cohort: a prospective study of tobacco use among Swedish twins.

Authors:  Helena Furberg; Paul Lichtenstein; Nancy L Pedersen; Laura Thornton; Cynthia M Bulik; Caryn Lerman; Patrick F Sullivan
Journal:  Nicotine Tob Res       Date:  2008-12       Impact factor: 4.244

Review 9.  Effect of smokeless tobacco (snus) on smoking and public health in Sweden.

Authors:  J Foulds; L Ramstrom; M Burke; K Fagerström
Journal:  Tob Control       Date:  2003-12       Impact factor: 7.552

10.  European Union policy on smokeless tobacco: a statement in favour of evidence based regulation for public health.

Authors:  C Bates; K Fagerström; M J Jarvis; M Kunze; A McNeill; L Ramström
Journal:  Tob Control       Date:  2003-12       Impact factor: 7.552

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.